UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 119

Sortiert nach

Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia

Haematologica (Roma), 2013-04, Vol.98 (4), p.591-596

2013

Link zum Volltext

Verfügbarkeit prüfen

Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision-Making Pathway

Journal of the American Heart Association, 2023-02, Vol.12 (3), p.e028562-e028562

2023

Link zum Volltext

Verfügbarkeit prüfen

Thrombophilia testing in the inpatient setting: impact of an educational intervention

BMC medical informatics and decision making, 2019-08, Vol.19 (1), p.167-167, Article 167

2019

Link zum Volltext

Verfügbarkeit prüfen

A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myeloma

International journal of hematology, 2018-09, Vol.108 (3), p.267-273

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia

Haematologica (Roma), 2012-01, Vol.97 (1), p.30-37

2012

Link zum Volltext

Verfügbarkeit prüfen

Second‐line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: A single‐center experience

American journal of hematology, 2010-11, Vol.85 (11), p.877-881

2010

Link zum Volltext

Verfügbarkeit prüfen

Moxifloxacin–acetaminophen–warfarin interaction during bacille Calmette-Guérin treatment for bladder cancer

American journal of health-system pharmacy, 2011-05, Vol.68 (9), p.814-817

2011

Link zum Volltext

Verfügbarkeit prüfen

Iron deficiency anemia in pregnancy

Current opinion in obstetrics & gynecology, 2022-04, Vol.34 (2), p.69

2022

Link zum Volltext

Verfügbarkeit prüfen

Characteristics associated with diagnostic yield of imaging for deep venous thrombosis and pulmonary embolism in the emergency department, hospital, and office settings: An Optum Clinformatics claims database study (2015–2019)

Thrombosis research, 2023-04, Vol.224, p.4-12

2023

Link zum Volltext

Verfügbarkeit prüfen

Prochemerin cleavage by factor XIa links coagulation and inflammation

Blood, 2018-01, Vol.131 (3), p.353-364

2018

Link zum Volltext

Verfügbarkeit prüfen

An Electronic Best Practice Alert Based on Choosing Wisely Guidelines Reduces Thrombophilia Testing in the Outpatient Setting

Journal of general internal medicine : JGIM, 2019-01, Vol.34 (1), p.29-30

2019

Link zum Volltext

Verfügbarkeit prüfen

Eculizumab Induces Sustained Remission in a Patient With Refractory Primary Catastrophic Antiphospholipid Syndrome

Journal of clinical rheumatology, 2015-09, Vol.21 (6), p.311

2015

Link zum Volltext

Verfügbarkeit prüfen

Blood and Guts: Diarrhea from Colonic Involvement in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Digestive diseases and sciences, 2019-02, Vol.64 (2), p.345-348

2019

Link zum Volltext

Verfügbarkeit prüfen

Routine Use of Gemtuzumab Ozogamicin in 7+3-Based Inductions for All “Non-Adverse” Risk AML

Blood, 2020-11, Vol.136 (Supplement 1), p.36-37

2020

Link zum Volltext

Verfügbarkeit prüfen

Hemorrhage risk of direct oral anticoagulants in real-world venous thromboembolism patients

Thrombosis research, 2021-08, Vol.204, p.126-133

2021

Link zum Volltext

Verfügbarkeit prüfen

Using Electronic Best Practice Alerts to Improve Thrombophilia Testing Based on ASH Choosing Wisely Guidelines

Blood, 2017-12, Vol.130, p.3355-3355

2017

Link zum Volltext

Verfügbarkeit prüfen

Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9

Pharmacogenetics and genomics, 2010-07, Vol.20 (7), p.407-413

2010

Link zum Volltext

Verfügbarkeit prüfen

Routine use of gemtuzumab ozogamicin in 7 + 3-based inductions for all 'non-adverse' risk AML

Leukemia & lymphoma, 2021-05, Vol.62 (6), p.1510-1513

2021

Link zum Volltext

Verfügbarkeit prüfen

Accessory splenules in autoimmune hemolytic anemia

American journal of hematology, 2013-02, Vol.88 (2), p.156-156

2013

Link zum Volltext

Verfügbarkeit prüfen

Magnitude of Potentially Inappropriate Thrombophilia Testing in the Inpatient Hospital Setting

Journal of hospital medicine, 2017-09, Vol.12 (9), p.735-738

2017

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and Financial Impact of Inappropriate Thrombophilia Testing in the Inpatient Hospital Setting: A Retrospective Analysis

Blood, 2016-12, Vol.128 (22), p.2330-2330

2016

Link zum Volltext

Verfügbarkeit prüfen

Sequential azacitidine plus lenalidomide in previously treated elderly patients with acute myeloid leukemia and higher risk myelodysplastic syndrome

Leukemia & lymphoma, 2016-03, Vol.57 (3), p.609-615

2016

Link zum Volltext

Verfügbarkeit prüfen

Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemia

Leukemia research, 2014-12, Vol.38 (12), p.1441-1445

2014

Link zum Volltext

Verfügbarkeit prüfen

A phase 1, open‐label, dose‐escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma

British journal of haematology, 2016-04, Vol.173 (2), p.253-259

2016

Link zum Volltext

Verfügbarkeit prüfen

Change In Albumin Levels During Induction Predicts Survival Outcomes In Adult Acute Lymphoblastic Leukemia

Blood, 2013-11, Vol.122 (21), p.1403-1403

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(107)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia

Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision-Making Pathway

Thrombophilia testing in the inpatient setting: impact of an educational intervention

A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myeloma

Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia

Second‐line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: A single‐center experience

Moxifloxacin–acetaminophen–warfarin interaction during bacille Calmette-Guérin treatment for bladder cancer

Iron deficiency anemia in pregnancy

Characteristics associated with diagnostic yield of imaging for deep venous thrombosis and pulmonary embolism in the emergency department, hospital, and office settings: An Optum Clinformatics claims database study (2015–2019)

Prochemerin cleavage by factor XIa links coagulation and inflammation

An Electronic Best Practice Alert Based on Choosing Wisely Guidelines Reduces Thrombophilia Testing in the Outpatient Setting

Eculizumab Induces Sustained Remission in a Patient With Refractory Primary Catastrophic Antiphospholipid Syndrome

Blood and Guts: Diarrhea from Colonic Involvement in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Routine Use of Gemtuzumab Ozogamicin in 7+3-Based Inductions for All “Non-Adverse” Risk AML

Hemorrhage risk of direct oral anticoagulants in real-world venous thromboembolism patients

Using Electronic Best Practice Alerts to Improve Thrombophilia Testing Based on ASH Choosing Wisely Guidelines

Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9

Routine use of gemtuzumab ozogamicin in 7 + 3-based inductions for all 'non-adverse' risk AML

Accessory splenules in autoimmune hemolytic anemia

Magnitude of Potentially Inappropriate Thrombophilia Testing in the Inpatient Hospital Setting

Prevalence and Financial Impact of Inappropriate Thrombophilia Testing in the Inpatient Hospital Setting: A Retrospective Analysis

Sequential azacitidine plus lenalidomide in previously treated elderly patients with acute myeloid leukemia and higher risk myelodysplastic syndrome

Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemia

A phase 1, open‐label, dose‐escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma

Change In Albumin Levels During Induction Predicts Survival Outcomes In Adult Acute Lymphoblastic Leukemia

Suchergebnisse filtern